Colorectal Cancer - Pipeline Review, H2 2016 - Therapeutics Assessment by Drug Target, MoA, RoA & Molecule Type - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Colorectal Cancer - Pipeline Review, H2 2016" report to their offering.

Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools and weight loss with no known reason. Treatment includes surgery, radiation therapy and chemotherapy.

This report provides comprehensive information on the therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colorectal Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • 2cureX ApS
  • 3-V Biosciences Inc
  • 3M Drug Delivery Systems
  • 3SBio Inc
  • 4SC AG
  • AB Science SA
  • AbbVie Inc
  • AbGenomics International Inc
  • Accelerated Pharma Inc
  • Adamed Sp z oo
  • Aduro BioTech Inc
  • Advenchen Laboratories LLC
  • Alchemia Ltd
  • Allinky Biopharma
  • Amal Therapeutics SA
  • (200+ More)

Key Topics Covered:

  1. Introduction
  2. Colorectal Cancer Overview
  3. Therapeutics Development
  4. Pipeline Products for Colorectal Cancer - Overview
  5. Pipeline Products for Colorectal Cancer - Comparative Analysis
  6. Colorectal Cancer - Therapeutics under Development by Companies
  7. Colorectal Cancer - Therapeutics under Investigation by Universities/Institutes
  8. Colorectal Cancer - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Colorectal Cancer - Products under Development by Companies
  13. Colorectal Cancer - Products under Investigation by Universities/Institutes
  14. Colorectal Cancer - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/n4f5tf/colorectal_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Colon Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Colon Cancer Drugs